AMA
Pooled COVID-19 Sample Testing a Potential Coverage Loophole for Insurers
Saying pooled testing for coronavirus was not for diagnostic purposes, Cigna had said it wouldn't reimburse for the method, but it plans to change its policy.
Laboratory, Provider Organizations Urge HHS to Update COVID-19 Testing Prioritization Guidelines
The letter cited the strain on non-COVID-19 care as laboratories struggle to meet demand for pre-procedure COVID-19 testing and other molecular tests.
Coronavirus Antibody Testing Inappropriate for Individuals, Medical Experts Tell Congress
The experts said that antibody testing cannot indicate an individual's immunity or help with return-to-work schemes but have use for public health agencies.
CMS Sets Reimbursement Rates for SARS-CoV-2 Serology Tests
The reimbursement rates for the most commonly performed SARS-CoV-2 serologic tests are $42.13 and $45.23, depending on the billing code used.
The cell collection device already has FDA clearance, while the firm intends to conduct trials in support of a filing for marketing clearance of the assay.Â